Biologics

12 major players in the global platelet rich plasma market

The global platelet rich plasma market is projected to increase from 2018 through 2026 at a 13.3 percent compound annual growth rate, according to a Credence Research report.

By: Staff

Monday, August 6th, 2018

Here are 12 key market players:

1. Arthrex

2. Arteriocyte Medical Systems

3. DePuy Synthes

4. Biomet

5. Cesca Therapeutics

6. Dr. PRP America

7. EmCyte Corp.

8. AdiStem

9. Exactech

10. Nuo Therapeutics

11. Regen Lab

12. Harvest Technologies Corp.

More articles on biologics:
RTI Surgical & Aziyo Biologics ink deal: 4 things to know
Asterias Biotherapeutics’ stem cell-derived treatment for spinal cord injury holds promise: 4 things to know
Ortho RTi receives extension on 2.1M+ warrants: 3 observations

Next Up in Biologics

TYBR Health debuts B3 Gel for orthopedics

Tammam Hanna, MD, an orthopedic surgeon in Lubbock, Texas, performed the first U.S. clinical case of TYBR Health’s B3 Gel…

By: Carly Behm
Tuesday, January 6th, 2026
4 orthobiologics updates

Here are four updates in spine and orthopedic biologics since Nov. 6. 1. Xtant Medical’s CollagenX wound healing product is…

By: Carly Behm
Thursday, December 18th, 2025
Cerapedics' PearlMatrix bone graft superior to local autograft: Study

A 24-month study of Cerapedics’ PearlMatrix P-15 peptide enhanced bone graft found it had better time-to-fusion and clinical success than…

By: Carly Behm
Wednesday, December 17th, 2025

Comments are closed.

Growth, mission + fragmentation: How academic health systems are confronting the next decade

Next Up in Biologics

TYBR Health debuts B3 Gel for orthopedics

4 orthobiologics updates

Cerapedics' PearlMatrix bone graft superior to local autograft: Study

Join the spine leaders & surgeons who start their day with Becker's